CN201828566U - Bilirubin content detection kit - Google Patents

Bilirubin content detection kit Download PDF

Info

Publication number
CN201828566U
CN201828566U CN2010205091292U CN201020509129U CN201828566U CN 201828566 U CN201828566 U CN 201828566U CN 2010205091292 U CN2010205091292 U CN 2010205091292U CN 201020509129 U CN201020509129 U CN 201020509129U CN 201828566 U CN201828566 U CN 201828566U
Authority
CN
China
Prior art keywords
reagent
detection kit
bilirubin
cholerythrin
reagent unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN2010205091292U
Other languages
Chinese (zh)
Inventor
王辉
王军峰
吴静
孟菲
王宇飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANGHAI ZHICHENG BIOTECHNOLOGY CO., LTD.
Original Assignee
SHANGHAI ZHICHENG BIOTECHNOLOGY CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI ZHICHENG BIOTECHNOLOGY CO Ltd filed Critical SHANGHAI ZHICHENG BIOTECHNOLOGY CO Ltd
Priority to CN2010205091292U priority Critical patent/CN201828566U/en
Application granted granted Critical
Publication of CN201828566U publication Critical patent/CN201828566U/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The utility model provides a bilirubin content detection kit which comprises a kit cover, a kit body and three agent units arranged on in the kit body, wherein the three agent units are respectively provided with at least one independent sealed container. The detection box has compact structure, is convenient to disassemble and assemble, simple to operate, and flexible to apply, has good stability, can meet requirements of different detection objects, and has low cost. The detection box can be simultaneously used for quickly detecting direct bilirubin and total bilirubin.

Description

The content of bilirubin detection kit
Technical field
The utility model belongs to medical science in-vitro diagnosis field, specifically is a kind of novel content of bilirubin detection kit that can be used for detecting bilirubin direct and total bilirubin content in the human blood simultaneously.
Background technology
Cholerythrin is the catabolite of haemachrome molecule in haemoglobin and the hemoprotein, because its mensuration to liver function, especially the discriminating of jaundice is significant, is the ancient and important problem of clinical medicine always, becomes one of normal project of doing in the clinical biochemical laboratory at present especially.Improved diazo reagent and be used for the mensuration of serum mesobilirubin from VandenBergh in 1916.From then on cholerythrin is named as direct reaction, hemobilirubin according to the pattern that itself and diazo reagent react, and sum of the two claims total bilirubin.
Be usually used in clinical detection cholerythrin method at present diazonium method, oxidation enzyme process, chemical oxidization method etc. are arranged.Wherein the diazo reagent method is historical the longest method, and principle is diazo salt and cholerythrin combination, under certain wavelength, and the variation that can produce absorbance.This method has the improvement of numerous species, and the main method of using has M-EShi method J-GShi method and improved method thereof.All be to generate diazo reagent by sulfanilic acid and sodium nitrite reaction then to react with cholerythrin.This method is swift in response, and is easy and simple to handle, and cost is lower, pretends to the high reagent of a kind of cost performance to be widely used.
The utility model content
The purpose of this utility model is to provide that a kind of cost is lower, stable performance, easy to use, and can satisfy the novel content of bilirubin detection kit that clinical bilirubin direct and total bilirubin detect simultaneously, can be formulated as bilirubin direct testing liquid and total bilirubin testing liquid, convenient clinical use according to different needs.
The utility model is achieved through the following technical solutions:
The utility model provides a kind of content of bilirubin detection kit, and three reagent unit that comprise lid, box body and place box body, described reagent unit comprise that respectively at least one is loaded with the independent sealed container of liquid.Specifically, three reagent unit are loaded with reagent 1 liquid, accelerator liquid and reagent 2 liquid respectively.
Described box body can be square shape or rectangular shape, and lid has shape correspondingly; Lid can monolaterally be connected on the box body, or separate with box body.
The autonomous container of described three reagent unit is a reagent bottle, and described reagent bottle is made up of bottle and bottle cap.Reagent bottle can be cylindrical, four prism type or other shapes.
Described three reagent unit are placed independently of one another, or form one by the autonomous container outer wall is directly continuous, or connect as one by support, and described support is selected from ring support or platform-type support.
The utility model content of bilirubin detection kit kit also includes fixture, and fixture is filled in around the independent sealed container, and described fixture is selected from a kind of of polyfoam, sponge.Fixture is filled in around the independent sealed container, plays effect fixing, antidetonation.
Described reagent 1 liquid comprises: the phosphoric acid of Ph2.0-4.0 or citrate buffer solution, content are 0.1mmol/L-2.0mmol/L, stabilizing agent glycerine or trehalose 1%-10% and sulfanilic acid 10mmol/L-20mmol/L.
Described accelerator liquid comprises dimethyl sulfoxide 20-70%, tween 5%-15%, polyoxyethylene laurel ether 5%-10%.
Comprise sodium nitrite 2mmol/L-10mmol/L in described reagent 2 liquid, stabilizing agent glycerine or trehalose 1%-10%.
Wherein to be mixed into volume ratio that working fluid can be used at 1: 1 be the bilirubin direct content detection for reagent 1 and reagent 2, and reagent 1, accelerator and reagent 2 are mixed into working fluid with volume ratio and can be used for the total bilirubin content detection at 1: 1: 1.Can satisfy different detection demands easily.
The design concept of the utility model kit is as follows: reagent 1 with can generate diazo salt rapidly after reagent 2 mixes, can be used for bilirubin direct and detect; Reagent 1, accelerator and after reagent 2 mixed, reagent 1 generated diazo salts fast with reagent 2, this diazo salt can be used for total bilirubin detection in the sample in the presence of accelerator.
After being formulated as working fluid, present commercially available diazonium method detectable generally can stablize 6-8 hour in room temperature, experimental results show that this novel cholerythrin detection kit has higher stability, be formulated as respectively that at room temperature to place after 12 hours accuracy in detection and linearity behind bilirubin direct working fluid and the total bilirubin working fluid still better.In addition, the utility model kit has been integrated bilirubin direct and total bilirubin, can be used for the detection demand of straight courage and total two projects of courage simultaneously, and the user of service can reduce the waste of reagent to a certain extent according to detecting needs preparation working fluid.And cost is lower, and is simple to operate.In addition, prove that by experiment this method and vanadate oxidizing process detect cholerythrin and have stronger correlativity.
Below the utility model is described in further detail by the drawings and specific embodiments, and embodiment provides with the purpose of giving an example, and does not constitute any restriction of the present utility model.
Description of drawings
Three-dimensional structure diagram when Fig. 1 opens for the utility model lid.
Fig. 2 is three reagent unit laying state synoptic diagram in airtight box body.
Fig. 3 is three reagent unit of one for being connected by the autonomous container outer wall.
Fig. 4 is the sectional view of Fig. 3 along the B-B line.
Three reagent unit of Fig. 5 for adopting ring support to connect as one.
Three reagent unit of Fig. 6 for adopting platform-type support to connect as one.
Wherein, 1 is lid, and 2 is box body, and 3 is first reagent unit, and 4 is second reagent unit, and 5 is the 3rd reagent unit, and 6 is fixture, and 7 for connecting support.
Embodiment
Embodiment 1
As Fig. 1 and Fig. 2, the utility model content of bilirubin detection kit, comprise lid 1 and box body 2, and first reagent unit 3, second reagent unit 4, the 3rd reagent unit 5, each reagent unit is made up of a sealable reagent bottle, and three reagent unit are loaded with pretreatment liquid respectively, and NBT method fructosamine is measured reagent, albumin measuring reagent, the mentioned reagent sequence of unit is positioned in the box body 2.
The utility model lid 1 and box body 2 can be airtight, use front opening.
Embodiment 2
The independent sealed container of three reagent unit of the utility model content of bilirubin detection kit can be connected with each other, form one, as Fig. 3 and Fig. 4, the outer wall of forming the independent sealed container of first reagent unit 3, second reagent unit 4, the 3rd reagent unit 5 directly links to each other and forms one.
Embodiment 3
The independent sealed container of three reagent unit of the utility model content of bilirubin detection kit can be connected with each other, form one, as Fig. 5 and Fig. 6, the outer wall of forming the independent sealed container of first reagent unit 3, second reagent unit 4, the 3rd reagent unit 5 connects as one by support 7, Fig. 5 and Fig. 6 are the support of two kinds of different structures and shape, are respectively ring support and platform-type support.

Claims (7)

1. a content of bilirubin detection kit is characterized in that, three reagent unit that comprise lid, box body and place box body, described reagent unit comprise that respectively at least one is loaded with the independent sealed container of liquid reagent.
2. a kind of cholerythrin detection kit as claimed in claim 1 is characterized in that the autonomous container of described three reagent unit is a reagent bottle, and described reagent bottle is made up of bottle and bottle cap.
3. a kind of cholerythrin detection kit as claimed in claim 1 is characterized in that, described three reagent unit are placed independently of one another.
4. a kind of cholerythrin detection kit as claimed in claim 1 is characterized in that, described three reagent unit directly link to each other by the autonomous container outer wall and form one.
5. a kind of cholerythrin detection kit as claimed in claim 1 is characterized in that, described three reagent unit connect as one by support.
6. a kind of cholerythrin detection kit as claimed in claim 5 is characterized in that described support is selected from ring support or platform-type support.
7. a kind of cholerythrin detection kit as claimed in claim 1 is characterized in that described kit also includes fixture, and fixture is filled in around the independent sealed container, and described fixture is selected from a kind of of polyfoam, sponge.
CN2010205091292U 2010-08-26 2010-08-26 Bilirubin content detection kit Expired - Lifetime CN201828566U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010205091292U CN201828566U (en) 2010-08-26 2010-08-26 Bilirubin content detection kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010205091292U CN201828566U (en) 2010-08-26 2010-08-26 Bilirubin content detection kit

Publications (1)

Publication Number Publication Date
CN201828566U true CN201828566U (en) 2011-05-11

Family

ID=43967092

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010205091292U Expired - Lifetime CN201828566U (en) 2010-08-26 2010-08-26 Bilirubin content detection kit

Country Status (1)

Country Link
CN (1) CN201828566U (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102226768A (en) * 2011-03-17 2011-10-26 郑州兰森生物技术有限公司 Reagent for determining total bilirubin by sodium nitrite oxidation method
CN110261625A (en) * 2019-07-15 2019-09-20 三诺生物传感股份有限公司 A kind of bilirubin multiplexed detection reagents box and its application method
CN110274881A (en) * 2018-03-14 2019-09-24 济南煊赫生物科技有限公司 A kind of stabilization, total bilirubin (enzymatic measurement) detection reagent of strong antijamming capability and detection method

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102226768A (en) * 2011-03-17 2011-10-26 郑州兰森生物技术有限公司 Reagent for determining total bilirubin by sodium nitrite oxidation method
CN102226768B (en) * 2011-03-17 2012-10-03 郑州兰森生物技术有限公司 Reagent for determining total bilirubin by sodium nitrite oxidation method
CN110274881A (en) * 2018-03-14 2019-09-24 济南煊赫生物科技有限公司 A kind of stabilization, total bilirubin (enzymatic measurement) detection reagent of strong antijamming capability and detection method
CN110261625A (en) * 2019-07-15 2019-09-20 三诺生物传感股份有限公司 A kind of bilirubin multiplexed detection reagents box and its application method

Similar Documents

Publication Publication Date Title
CN106198527B (en) A kind of ascorbic acid interference multi-term urine analysis test paper and preparation method thereof
CN100564538C (en) Alpha-L-fucosidase activity determination method and alpha-L-fucosidase diagnostic reagent
CN108435266A (en) A kind of micro-fluidic detection chip and the kit based on it, whole blood multiple determination methods and applications
JP2016532876A (en) Equipment, systems, methods and kits for receiving wipes
CN104995310A (en) Rapid, low-sample-volume cholesterol and triglyceride assays
CN207472761U (en) A kind of micro-fluidic detection chip and the kit for whole blood multiple determination
CN201828566U (en) Bilirubin content detection kit
JP2016529490A (en) Device and method for sampling biological fluid and dispensing biological fluid using a capillary tube, and biological analytical instrument
CN103048282B (en) Detection method of bilirubin and detection kit
CN201955341U (en) Diagnostic instrument for oral liquid
Bowers et al. Rapid-flow enthalpimetric determination of urea in serum, with use of an immobilized urease reactor.
CN102749458A (en) Cystatin C detection kit and preparing method thereof
CN103940817B (en) A kind of liquid sample collecting detector of built-in reagent
CN103543279B (en) Portable quantitative detecting device for blood
CN102914520B (en) Surface plasmon resonance biosensor for detecting tuberculosis, preparation method and application of surface plasmon resonance biosensor
CN108872228A (en) A kind of emiction sampling cup of novel integrated urine detection
CN102747133A (en) Adenosine deaminase (ADA) detection reagent kit and preparation method thereof
CN208621519U (en) A kind of urine list hydrocarbon phenolic metabolism object assay kit
CN208860748U (en) A kind of emiction sampling cup of novel integrated urine detection
CN202916128U (en) Sampling device for urine chemical examination
CN203432974U (en) High-throughput thioredoxin activity detection kit
CN202465714U (en) Alkaline phosphatase kit
CN203858203U (en) Liquid sample collection detector with internal reagent
CN204203233U (en) Aimmugen effect of inoculation Fast Evaluation kit
CN202404094U (en) Assay kit for concentration of rheumatoid factors

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP01 Change in the name or title of a patent holder

Address after: 201204 Shanghai city Pudong New Area Lianxi Road No. 1210 Building 2

Patentee after: Shanghai Zhicheng Biological Technology Co.,Ltd.

Address before: 201204 Shanghai city Pudong New Area Lianxi Road No. 1210 Building 2

Patentee before: Shanghai Zhicheng Biotechnology Co., Ltd.

C56 Change in the name or address of the patentee
CP02 Change in the address of a patent holder

Address after: 201204, Lane 3399, Lane 6, Kang Xin Road, Shanghai, Pudong New Area

Patentee after: Shanghai Zhicheng Biological Technology Co.,Ltd.

Address before: 201204 Shanghai city Pudong New Area Lianxi Road No. 1210 Building 2

Patentee before: Shanghai Zhicheng Biological Technology Co.,Ltd.

CP01 Change in the name or title of a patent holder

Address after: 201204, Lane 3399, Lane 6, Kang Xin Road, Shanghai, Pudong New Area

Patentee after: SHANGHAI ZHICHENG BIOTECHNOLOGY CO., LTD.

Address before: 201204, Lane 3399, Lane 6, Kang Xin Road, Shanghai, Pudong New Area

Patentee before: Shanghai Zhicheng Biological Technology Co.,Ltd.

CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20110511